Novel drug delivery systems for inner ear protection and regeneration after hearing loss
about
Enhanced auditory neuron survival following cell-based BDNF treatment in the deaf guinea pig.Effects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats.Brain-derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats.Dexamethasone released from cochlear implant coatings combined with a protein repellent hydrogel layer inhibits fibroblast proliferation.Hydrogel coated and dexamethasone releasing cochlear implants: quantification of fibrosis in guinea pigs and evaluation of insertion forces in a human cochlea model.Neurotrophins and cochlear implants: a solution to sensorineural deafness?Developments in delivery of medications for inner ear disease.Perilymph pharmacokinetics of marker applied through a cochlear implant in guinea pigs.Dual Release Carriers for Cochlear Delivery.A hydrogel coating for cochlear implant arrays with encapsulated adipose-derived stem cells allows brain-derived neurotrophic factor delivery.The effect of surface charge of glycerol monooleate-based nanoparticles on the round window membrane permeability and cochlear distribution.Biodegradable polymeric coatings on cochlear implant surfaces and their influence on spiral ganglion cell survival.An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders.Application of a TNF-alpha-inhibitor into the scala tympany after cochlear electrode insertion trauma in guinea pigs: preliminary audiologic results.Cochlear implantation in adolescents with prelinguistic deafness.
P2860
Q28740987-390EC1DB-42C9-4246-AE9B-CD795C2E0045Q30440839-9D7E5199-9B52-42E1-B764-E811BF78D517Q30467124-28B51C0D-D044-4653-8DFB-387F4EFD468DQ34637454-B57091A5-01BE-43A6-80F1-BFED8666EFB0Q35165610-0CA64C56-B1F8-4AE4-AA17-B5CB46DAD85CQ38034287-1D27180B-223B-437E-8E02-B67556164701Q38096427-14BC699B-8531-4FE3-9892-0D44D7158438Q38619862-7F4BBDC7-5EC9-48EC-8A3A-8D55C854117AQ38852651-0CF7CC2A-33B3-4230-AF65-8922FD406E27Q39013957-583C8D8B-0E67-4E17-AA01-1C615EF2BE95Q39110356-4FDA2E83-99B7-40C6-9ECC-CDD36E15609CQ42452622-A1C50DE5-7A99-4D7C-BB68-7F9F2C324B8DQ45887696-62F25560-D3CD-4ECC-9FA9-B46BBC9984EDQ48486853-9CD78F88-C203-4265-9096-E36641E950B5Q50437944-CEFFDEF1-C662-4EE2-BA38-A0893C94280E
P2860
Novel drug delivery systems for inner ear protection and regeneration after hearing loss
description
article
@en
im September 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2008
@uk
name
Novel drug delivery systems for inner ear protection and regeneration after hearing loss
@en
Novel drug delivery systems for inner ear protection and regeneration after hearing loss
@nl
type
label
Novel drug delivery systems for inner ear protection and regeneration after hearing loss
@en
Novel drug delivery systems for inner ear protection and regeneration after hearing loss
@nl
prefLabel
Novel drug delivery systems for inner ear protection and regeneration after hearing loss
@en
Novel drug delivery systems for inner ear protection and regeneration after hearing loss
@nl
P2860
P50
P1476
Novel drug delivery systems for inner ear protection and regeneration after hearing loss
@en
P2093
Jacqueline K Andrew
P2860
P304
P356
10.1517/17425247.5.10.1059
P407
P577
2008-10-01T00:00:00Z